Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Druzhestven N IzsledovatelskifiledCriticalDruzhestven N Izsledovatelski
Priority to BG9079389ApriorityCriticalpatent/BG49852A1/en
Publication of BG49852A1publicationCriticalpatent/BG49852A1/en
The medicinal form ensures a thorough wetting of the treated surfaces and a high therapeutical effect for the constituent medicinal substances. The form contains, in percent (w/w): 85-95 liquid glycols, 3.5-4.5 surface-active agent, 0.5-0.6 absolute ethyl alcohol, 9-11 propellant and 0.5-1.5 active substance. The surface-active agent is polyoxyethylen-10-stearylether and the propellant is dichlorodifluoromethane.
BG9079389A1989-12-291989-12-29Local medicine form
BG49852A1
(en)
An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
Process for the production of medical preparations for preventing proline-and lysine-hydroxylase and process for the production of some of the active agents
UNSaturated cycloaliphatic esters of MACROLIDIC AND LINCOSAMIDIC ANTIBIOTICS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM.